SalMar - 2018 share-based incentive scheme for senior

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
47
SalMar - 2018 share-based incentive scheme for senior executives and key personnel

In accordance with the authorisation granted by the AGM on 5 June 2018, the board of directors of SalMar ASA has decided to establish a share-based incentive scheme (Restricted Share Unit Plan) for senior executives and key personnel employed by the company and its subsidiaries. The scheme encompasses up to 129 467 shares and has a duration of three years. The company's liability with respect to the scheme will be met through existing holdings of treasury shares. As of 21 January 2019, SalMar ASA holds 561 003 treasury shares.

The purpose of the share-based incentive scheme (RSUP) is to encourage employees to maintain a deep, long-term engagement in the company, through a further alignment of the employees' interests with those of other shareholders. Under the RSUP, participating individuals will be awarded shares to motivate them to contribute to the continued success and profitability of the company, as well as deliver outstanding results. The RSUP will also enhance SalMar's ability to attract and retain staff.

Under the RSUP, participants will receive, free of charge, Restricted Share Units (RSUs), which, if certain predefined performance criteria are met within an accrual period, will be released and transferred to them as shares. The RSUP comprises three accrual periods of one, two and three calendar years respectively, with 2018 being the first year. Each accrual period encompasses 1/3 of the total number of RSUs included in the scheme. One RSU gives a contingent entitlement to one share.

The following criteria determine the award of RSUs during each of the three accrual periods: - Award of 1/3 of the RSUs is independent of any performance criteria - Award of 1/3 of the RSUs depends on SalMar achieving a certain EBIT/kg more than other aquaculture companies listed on the Oslo Stock Exchange during the accrual period - Award of 1/3 of the RSUs depends on SalMar's shares achieving a higher total shareholder return (TSR) than a defined group of comparable companies during the accrual period.

Accrual of RSUs under the scheme presumes that the individual is an employee of SalMar or a participating subsidiary. The total gain from released RSUs during one calendar year shall not exceed 100 per cent of the participant's basic salary. Under the scheme's rules, the number of RSUs will be adjusted in the event of a dividend payout in order to preserve, but not increase, the value of the RSU allocation.

The RSUP goes into effect on 21 January 2019 and encompasses senior executives and key personnel at SalMar and its subsidiaries.

Restricted share units granted primary insiders 21 January 2019:

Frode Arntsen has received 2 377 RSUs in the Company Geir Berg has received 826 RSUs in the Company Olav Andreas Ervik has received 3 479 RSUs in the Company Roger Bekken has received 2 435 RSUs in the Company Runar Sivertsen has received 985 RSUs in the Company Tonette Bjørgård has received 1 426 RSUs in the Company Ulrik Steinvik has received 2 092 RSUs in the Company 

New holdings:

After completion of the abovementioned grant Frode Arntsen holds 5 171 RSUs in the Company. As of today the primary insider holds 736 shares in the Company.

After completion of the abovementioned grant Geir Berg holds 2 371 RSUs in the Company. As of today the primary insider holds 0 shares in the Company.

After completion of the abovementioned grant Olav Andreas Ervik holds 8 303 RSUs in the Company. As of today the primary insider holds 12 217 shares in the Company.

After completion of the abovementioned grant Roger Bekken holds 5 709 RSUs in the Company. As of today the primary insider holds 3 715 shares in the Company.

After completion of the abovementioned grant Runar Sivertsen holds 2 492 RSUs in the Company. As of today the primary insider holds 1 024 shares in the Company.

After completion of the abovementioned grant Tonette Bjørgård holds 4 090 RSUs in the Company. As of today the primary insider holds 4 000 shares in the Company.

After completion of the abovementioned grant Ulrik Steinvik holds 5 996 RSUs in the Company. As of today the primary insider holds 13 882 shares in the Company.

 

For more information, please contact: CFO Trond Tuvstein, Tel: + 47 918 53 139 Email: trond.tuvstein@salmar.no Website: www.salmar.no

This information is subject of the disclosure requirements pursuant to section

5-12 of the Norwegian Securities Trading Act.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 3

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 1

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 5

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading
USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 7

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 3

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 5

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
OneOdio Showcases Innovation at IFA 2026 in Berlin

Updated Category News Views 5

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Continue Reading
Pizza: The Unlikely Symbol of Universal Togetherness

Updated Category News Views 6

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Continue Reading

Top 5 Most Recently Viewed Articles

Arch Capital Group Achieves $978 Million in Q3 Earnings

Updated Category News Views 135

Arch Capital Group Reports Third Quarter Financial Success Arch Capital Group Ltd. (NASDAQ: ACGL) recently announced strong financial results for the third quarter. This report signifies a remarkable achievement for the company as it reflects the overall financial health and operational efficiency across its diverse business segments. Strong Financial Performance The net...

Continue Reading
Unleashing Potential: BexBack's Innovative Crypto Trading

Updated Category News Views 131

Welcome to the New Era of Cryptocurrency Trading with BexBack The cryptocurrency market is known for its unpredictability, and with Bitcoin's price teetering around $100,000, many traders find themselves navigating a landscape filled with uncertainty. In such a turbulent environment, seasoned investors are increasingly turning to futures trading with 100x leverage to...

Continue Reading
MasHash Unveils Revolutionary Cloud Mining Platform

Updated Category News Views 292

MasHash Launches Innovative Cloud-Based Mining Platform MasHash, a prominent provider of cloud-based cryptocurrency mining solutions, has unveiled its latest and improved mining platform. This new offering aims to revolutionize how users participate in crypto mining and enhance their profitability. The Growing Significance of Crypto Mining in 2024 As we enter 2024, the...

Continue Reading
Syndax Pharmaceuticals Plans Engaging Investor Event Soon

Updated Category News Views 29

Investor Event Scheduled for December Syndax Pharmaceuticals (Nasdaq: SNDX), a pioneering biopharmaceutical company renowned for its cutting-edge cancer treatments, has announced an upcoming investor event. This event will allow attendees to engage directly with the Syndax team and learn more about the groundbreaking research being conducted in the field of oncology....

Continue Reading
Introducing Seguritech's Smartwatch for Safety and Health Monitoring

Updated Category News Views 178

Introducing Seguritech's Innovative Smartwatch Seguritech has taken a bold step in personal safety with the introduction of its Early Warning Smartwatch. This remarkable device connects users seamlessly to a network of Command and Control Centers, ensuring immediate access to emergency responders in critical situations. Key Features of the Early Warning Smartwatch The...

Continue Reading